The Healthspan Map · Ch3 Baseline: Body composition
Waist-to-height ratio
What this is linked to
| Nutrient or lever | Direction | Strength | Evidence type | What was found | Source |
|---|---|---|---|---|---|
| Waist-to-height ratio | Watch this | Moderate | RCT / meta-analysis | Central/visceral adiposity drives insulin resistance and sympathetic activation that raise blood pressure, beyond overall weight. | Non-drug BP management (opens in a new tab) |
| Waist-to-height ratio | Watch this | Moderate | Review / narrative | Central adiposity is linked to higher triglycerides and lower HDL; reducing it improves lipids. | Lifestyle & lipids (Endotext) (opens in a new tab) |
| Waist-to-height ratio | Watch this | Moderate | Cohort / observational | Central adiposity (waist-to-height ratio) predicts knee, back and joint pain better than BMI and independent of it, driving earlier osteoarthritis symptoms. | Central obesity & OA onset (opens in a new tab) |
| Waist-to-height ratio | Watch this | Emerging | RCT / meta-analysis | Central/visceral adiposity (tracked by waist-to-height ratio) is linked to poorer bone microarchitecture and higher hip-fracture risk via inflammation and insulin resistance - even though overall body weight raises BMD. Reducing it with diet, activity and sleep is a sensible adjunct. Evidence is emerging/mixed. | Central adiposity & bone (VAT review) (opens in a new tab) |
| Waist-to-height ratio | Watch this | Moderate | Review / narrative | Central adiposity promotes insulin resistance and metabolic dysfunction that damage peripheral nerves. | Diabetic neuropathy review (opens in a new tab) |
| Waist-to-height ratio | Watch this | Moderate | Cohort / observational | Waist-based central-adiposity measures track reduced fertility beyond BMI alone. | Nutritional status & female infertility case-control (PMC11496271) (opens in a new tab) |
| Waist-to-height ratio | Watch this | Moderate | Cohort / observational | Waist-based adiposity measures capture the upper-body fat that raises airway collapsibility. | OSA & obesity review (PMC10876414) (opens in a new tab) |
| Waist-to-height ratio | Watch this | Emerging | Cohort / observational | Central adiposity and cardiometabolic risk are associated with tinnitus - emerging. | Tinnitus & cardiovascular risk (opens in a new tab) |
| Waist-to-height ratio | Watch this | Strong | Review / narrative | Increased waist circumference (visceral fat) marks high type 2 diabetes risk; waist-based ratios are core metabolic-syndrome criteria and drive insulin resistance. | Prevention and management of type 2 diabetes: dietary components and nutritional strategies (Lancet) (opens in a new tab) |
| Waist-to-height ratio | Watch this | Moderate | Review / narrative | Waist-based adiposity predicts CRP/IL-6 elevation largely independent of BMI. | Central adiposity & CRP (opens in a new tab) |
| Waist-to-height ratio | Watch this | Strong | RCT / meta-analysis | WHtR had the greatest discriminatory power for the cardiometabolic-risk cluster. | Ashwell et al., Obesity Reviews 2012 (>300,000 adults) (opens in a new tab) |
| Waist-to-height ratio | Watch this | Moderate | Cohort / observational | Higher WHtR predicted cardiovascular hospitalization and all-cause and obesity-related mortality. | WHtR and mortality prospective cohort, Frontiers in Nutrition 2025 (opens in a new tab) |
| Waist-to-height ratio | Watch this | Moderate | Cohort / observational | Central adiposity tracks fatty-liver severity and metabolic-kidney risk; reducing it improves hepatic fat. | Hypocaloric diet & hepatic steatosis (PMC12455765) (opens in a new tab) |